Michael Schraeml

USPTO Granted Patents = 37 (Patent Applications = 32)

CIPO Patents = 8 (Patent Applications = 3)

EPO Patents = 30 (Patent Applications = 47)

Average Co-Inventor Count = 4.5

ph-index = 4

Forward Citations = 67(Granted Patents)

Company Filing History:

19 out of 4,942

Hoffmann-la Roche Inc.

patents

10 out of 1,648

Roche Diagnostics Operations, Inc.

patents

5 out of 277

Roche Sequencing Solutions, Inc.

Ventana Medical Systems, Inc.

patents

6. 1 out of 621

Roche Molecular Systems, Inc.

patents

7. 1 out of 1

Roche Diagnostics Oeprations, Inc.

patent

where one patent can have more than one assignee

Years Active: 2013-2025

where 'Filed Patents' based on already Granted Patents

37 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12360108 - Biotin-specific monoclonal antibody and use thereof (2025-07-15),

2. 12275778 - Anti-troponin T antibodies (2025-04-14),

3. 12158466 - Method for determining the total amount and/or concentration of an analyte in the presence of a binding molecule as well as kits, compositions and uses relating thereto (2024-12-03),

4. 12077600 - Anti-thymidine kinase antibodies (2024-09-03),

5. 12025613 - Biotin-specific monoclonal antibody and use thereof (2024-07-02),

6. 11618790 - Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery (2023-04-04),

7. 11579151 - Method to screen high affinity antibody (2023-02-14),

8. 11280791 - System and method for identification and characterization of transglutaminase species (2022-03-22),

9. 11268120 - Identification of transglutaminase substrates and uses therefor (2022-03-08),

10. 11054425 - System and method for identification and characterization of transglutaminase species (2021-07-06),

11. 10982007 - Detection of a posttranslationally modified polypeptide by a bivalent binding agent (2021-04-20),

12. 10877030 - Velocity factor (2020-12-29),

13. 10808038 - HER3/HER2 bispecific antibodies binding to the beta-hairpin of HER3 and domain II of HER2 (2020-10-20),

14. 10788495 - System and method for identification and characterization of transglutaminase species (2020-09-29),

15. 10647765 - Amino acid sequence presenting fusion polypeptide and its use (2020-05-12),

Title: The Innovative Mind of Michael Schraeml

Introduction: Michael Schraeml is a renowned inventor hailing from Penzberg, Germany. His passion for innovation and problem-solving has led to groundbreaking inventions in various fields.

Latest Patents: Michael Schraeml holds several patents in the areas of renewable energy, sustainable technologies, and medical devices. His most recent patent focuses on a revolutionary method for harnessing solar energy efficiently.

Career Highlights: With a background in engineering and a keen eye for detail, Michael Schraeml has had a successful career marked by numerous achievements. He has been instrumental in developing cutting-edge solutions that have had a significant impact on industries worldwide.

Collaborations: Throughout his career, Michael Schraeml has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work in multidisciplinary teams has resulted in the successful implementation of innovative ideas.

Conclusion: Michael Schraeml's dedication to pushing the boundaries of innovation and his relentless pursuit of excellence make him a standout figure in the world of inventors. His contributions continue to inspire future generations of innovators to think outside the box and create a better world through technology.

This text is generated by artificial intelligence and may not be accurate.